SEC Form 4 · accession 0001070081-17-000043
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Neil Gregory Almstead
Officer — EVP Research Pharma Ops & Tech
Period of report
Jan 3, 2017
Accepted (ET)
Jan 5, 2017 · 9:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 3, 2017 | A | 6,000 | $0.00 | A | 16,000 | D | |
| Common StockF2,F3 | Jan 3, 2017 | A | 720 | $0.00 | A | 2,765 | I | By spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right To Buy)F4 | $11.23 | Jan 3, 2017 | A | 35,000 | A | — | Jan 2, 2027 | Common Stock | 35,000 | 35,000 | D |
Explanation of responses
- F1Restricted stock award vests in four equal annual installments over four years, commencing on January 3, 2018.
- F2Restricted stock unit (RSU) award vests in four equal annual installments over four years, commencing on January 3, 2018. Upon vesting, each RSU will convert into one share of the issuer.
- F3Includes 750 RSUs (previously reported in Table II), granted on January 4, 2016, which vest in equal installments over four years on each anniversary of the grant date.
- F4This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.